NCT07029061

Brief Summary

Objective: Sensory impairment in the affected upper limb occurs in approximately 50% of post-stroke patients and negatively impacts functional capacity and quality of life. This pilot study aims to evaluate whether the standardized use of pneumatic (air) splints, as part of a neurodevelopmental treatment approach, will have a positive effect on sensorimotor deficits in the hemiplegic upper limb of post-stroke patients. Design: Pilot randomized, single-blind clinical trial. Setting: Brain injury rehabilitation facility. Participants: Twenty adults in the subacute phase after stroke will be randomized into two groups. The experimental group (n = 10) will receive air splint therapy combined with physiotherapy (45 minutes per session, twice per week for 4 weeks). The control group (n = 10) will receive only physiotherapy with the same duration and frequency. Sensorimotor outcomes will be assessed using the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE), and finger flexor/extensor strength will be measured using the Amadeo robotic system. Assessments will be conducted before and after the intervention. Conclusions: The addition of air splints to physiotherapy may enhance exteroceptive and proprioceptive sensitivity in adults recovering from stroke during the subacute phase.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2023

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 19, 2025

Completed
Last Updated

June 19, 2025

Status Verified

January 1, 2024

Enrollment Period

2 years

First QC Date

June 11, 2025

Last Update Submit

June 18, 2025

Conditions

Keywords

Physical TherapyAir splintsStrokeUpper LimbSensorimotor impairments

Outcome Measures

Primary Outcomes (1)

  • Change in upper limb sensorimotor function measured by the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE)

    Change in upper limb sensorimotor function measured by the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE), a validated stroke-specific scale. The FMA-UE ranges from 0 to 66, where higher scores indicate better motor and sensory function.

    Baseline and post 4-week intervention

Secondary Outcomes (4)

  • Change in trunk function measured by the Trunk Control Test (TCT)

    Baseline and after 4-week intervention

  • Change in balance performance measured by the Mini-Balance Evaluation Systems Test (Mini-BESTest)

    Baseline and after 4-week intervention

  • Change in hand strength (flexion and extension) measured using the AMADEO robotic system.

    Baseline and after 4-week intervention

  • Change in range of motion (ROM) of the shoulder and fingers measured using the AMADEO robotic system.

    Baseline and after 4-week intervention

Study Arms (2)

Application of CPPS (Urias splints) + physiotherapy Intervention Type: Device

EXPERIMENTAL
Device: Air splints

Physiotherapy alone following neurodevelopmental approach

NO INTERVENTION

Interventions

Application of CPPS (Urias splints) + physiotherapy

Application of CPPS (Urias splints) + physiotherapy Intervention Type: Device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke at least 2 months earlier
  • Mild/moderate hypertonia (Ashworth ≤3)
  • Proprioceptive and exteroceptive deficits
  • Trunk stability score between 8-23 (TCT)

You may not qualify if:

  • Non-vascular etiology
  • Clinical instability
  • Skin lesions or deformities
  • Botulinum toxin in last 3 months
  • Cognitive/communication limitations
  • Maximum TCT score (23) at baseline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alicia

Madrid, Madrid, 28007, Spain

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist (PhD)

Study Record Dates

First Submitted

June 11, 2025

First Posted

June 19, 2025

Study Start

June 12, 2020

Primary Completion

June 12, 2022

Study Completion

March 10, 2023

Last Updated

June 19, 2025

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations